Staar Surgical (STAA) Research & Development (2010 - 2026)

Staar Surgical has reported Research & Development for 17 years, with the latest figure at $9.9 million in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 12.47% year-over-year to $9.9 million; the trailing twelve-month figure through Apr 2026 stood at $38.6 million (down 14.56% YoY), and the FY2026 full-year result was $40.1 million, down 11.61% from the prior year.
• Research & Development for Q2 2026 stood at $9.9 million, up from $9.2 million in the prior quarter.
• The five-year high for Research & Development was $13.4 million in Q1 2024, with the low at $6.9 million in Q4 2023.
• Historically, Research & Development has averaged $10.2 million across 5 years, with a median of $9.9 million in 2026.
• Annual changes were most pronounced in 2023 — Research & Development fell 29.08% — and 2024, when it surged 40.73%.
• Staar Surgical's Research & Development stood at $9.8 million in 2022, then fell by 29.08% to $6.9 million in 2023, then soared by 40.73% to $9.8 million in 2024, then fell by 5.75% to $9.2 million in 2025, then increased by 7.78% to $9.9 million in 2026.
• The last three Research & Development figures came in at $9.9 million (Q2 2026), $9.2 million (Q1 2026), and $9.2 million (Q3 2025), per Business Quant data.